Fidelity Investments
HQL

Fidelity Investments’s abrdn Life Sciences Investors HQL Stock Holding History

Fidelity Investments’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2
Closed -$28 – 5597
2024
Q2 		$28 Buy
2
+1
+100% +$14 ﹤0.01% 5132
2024
Q1 		$14 Hold
1
– – ﹤0.01% 5235
2023
Q4 		$13 Buy
+1
New +$12 ﹤0.01% 5276
2023
Q3 		– Sell
-2
Closed -$27 – 5407
2023
Q2 		$27 Buy
2
+1
+100% +$14 ﹤0.01% 5120
2023
Q1 		$14 Buy
+1
New +$14 ﹤0.01% 5146
2022
Q4 		– Sell
-1
Closed – – 5462
2022
Q3 		$0 Buy
+1
New +$15 ﹤0.01% 5123
2022
Q1 		– Sell
-1
Closed – – 5206
2021
Q4 		$0 Hold
1
– – ﹤0.01% 4618
2021
Q3 		$0 Buy
+1
New +$21 ﹤0.01% 4651
2021
Q2 		– Sell
-1
Closed – – 4533
2021
Q1 		$0 Buy
+1
New +$21 ﹤0.01% 4237
2020
Q3 		– Sell
-1
Closed – – 3825
2020
Q2 		$0 Sell
1
-1
-50% -$17 ﹤0.01% 3853
2020
Q1 		$0 Buy
2
+1
+100% +$16 ﹤0.01% 3905
2019
Q4 		$0 Hold
1
– – ﹤0.01% 4000
2019
Q3 		$0 Hold
1
– – ﹤0.01% 3978
2019
Q2 		$0 Buy
+1
New +$16 ﹤0.01% 3933
2019
Q1 		– Sell
-1
Closed – – 3866
2018
Q4 		$0 Buy
+1
New +$18 ﹤0.01% 3793

Other funds holding HQL

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
AIA
Absolute Investment Advisers Rosemary Beach, Florida $852M AUM 0.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Fidelity Investments's HQL Position: Q3 2024 in Review

Fidelity Investments sold out of abrdn Life Sciences Investors (HQL) in Q3 2024, closing a stake of 2 shares — an estimated $28 sold.

Fidelity Investments first reported a position in HQL in Q4 2018 and held it in 15 quarters. The position peaked at $28 in Q2 2024. 74 funds tracked by Wall St. Rank hold HQL as of Q3 2024.

  • Fidelity Investments reported no remaining abrdn Life Sciences Investors position as of Q3 2024 after selling out during the quarter.
  • Fidelity Investments sold 2 abrdn Life Sciences Investors shares in Q3 2024, an estimated $28.
  • Fidelity Investments first reported a position in abrdn Life Sciences Investors in Q4 2018 and held it in 15 quarters.
  • Fidelity Investments's abrdn Life Sciences Investors position peaked at $28 in Q2 2024.
  • 74 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2024.

Based on Fidelity Investments's 13F filing for Q3 2024, filed 13 Nov 2024.